Clinical Trials Browser

Phase 3 × Clear-cell metastatic renal cell carcinoma × pembrolizumab × Clear all

NCT07383441 2026-02-03

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

Phase 3 Not yet recruiting

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell